Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Quattroflow™ to Feature Single-Use Biologic Pumps at INTERPHEX 2013

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
Single-use pumps save time and money, and are quick and easy to change.

Quattroflow™ from Almatec® Maschinenbau GmbH, has announced that it will display the latest offerings in its single-use line of pumps for use in biologic-handling applications within pharmaceutical and biotech operations at INTERPHEX 2013 in Booth No. 2463.

The INTERPHEX show, which brings together a wide variety of leaders from the pharmaceutical industry, will be held from April 23-25, 2013, at the Jacob K. Javits Convention Center in New York, NY, USA.

The incorporation of single-use pumps in biologic-handling applications is gaining wider acceptance among pharmaceutical and biotech manufacturers because they can help optimize end-product speed-to-market.

Single-use, or disposable, pumps feature replaceable wetted pump chamber, which is an advantage for manufacturers looking to maximize their production operations.

Quattroflow positive displacement pumps are ideal for single-use systems because they incorporate a four piston-diaphragm technology with no mechanical seals that is driven by an eccentric shaft and motor.

Quattroflow pumps primarily serve the pharmaceutical and biotech industries in applications that require high containment, purity and cleanability, and are best known for transferring shear-sensitive media of aqueous solutions and biological products without damage, ultimately ensuring product safety, efficiency and reliability.

Quattroflow pumps feature wetted pump chambers made of plastic, while the valves are made of EPDM and the diaphragms of EPDM/PP compound.

The Quattroflow product line consists of four sizes - QF150, QF1200, QF4400, QF5050 and QF20K - with capacities of 1 to 20,000 lph (5283 gph).

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos